Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2021 Mar 27;9(7):2761–2769.e2. doi: 10.1016/j.jaip.2021.02.053

Table 1.

Features of the participants. Data represent the median (25th, 75th percentile) or the number of participants (%).

Feature All participants N = 256

Age (years) 10.5 (8.5, 13.83)

Asthma duration (years) 8.0 (5.3, 11.3)

Male 158 (61.7)

Hispanic ethnicity 3 (1.2)

Race White 28 (10.9)
Black 214 (83.6)
More than one race 14 (5.5)

Household education Refused 14 (5.5)
Did not complete high school 11 (4.3)
High school 39 (15.2)
Some college 89 (34.8)
College degree 103 (40.2)

Parent with asthma 152 (61.3)

Smoker in household 37 (14.7)

Other diagnoses Obesity 70 (27.3)
Allergic rhinitis 221 (87.4)
Atopic dermatitis 150 (59.3)

Asthma medications Inhaled corticosteroid (any dose) 213 (83.2)
High-dose inhaled corticosteroid 122 (47.7)
Leukotriene receptor antagonist 156 (60.9)
Long-acting beta-agonist 133 (52.0)